For Immediate Release
Contact: Tom Capezzuto
At UMDNJ-New Jersey Medical School
UMDNJ Awarded CDC Grant to Gauge Outcomes
of Diabetes Care Within Managed Care Settings
The University of Medicine and Dentistry of New Jersey (UMDNJ)
has been awarded a $832,652 grant from the federal Centers for
Disease Control and Prevention (CDC) to participate in a new five-year
study of diabetes care within managed care settings.
The UMDNJ-New Jersey Medical School is one of six institutions
in the United States to share a $4.2 million CDC grant in a new
study known as Translating Research Into Action for Diabetes (TRIAD).
Dr. Norman L. Lasser, a professor of medicine at the UMDNJ-New
Jersey Medical School, is principal investigator of the study.
The TRIAD project was initiated by the CDC in 1998 to assess
the quality of diabetes care and identify the factors that affect
quality and outcomes of care. The new TRIAD study continues those
objectives and expands the project to accurately examine changes
in quality of care during the past five years.
"Our purpose is to try to help the CDC identify interventions
that may help people at high risk for diabetes to make the right
choices that will help prevent the disease," said Dr. Lasser,
a preventive cardiologist. "One of the study's primary components
is to develop methods to identify people who do not yet have diabetes
but are at high risk of developing this condition."
TRIAD is the largest multi-center study of diabetes and factors
affecting quality of care and quality of life for individuals
with diabetes. TRIAD includes 12,000 patients who represent a
wide cross-section of the U.S. population in terms of age, gender,
ethnicity and socioeconomic factors.
The project involves 10 U.S. health plans and 66 provider groups.
It is a collaborative effort between the National Institute for
Diabetes and Digestive and Kidney Diseases and the U.S. Department
of Veteran Affairs (VA).
"Numerous studies have demonstrated that diabetes care is less
than optimal," Dr. Lasser said. "TRIAD combines knowledge and
science to bridge the gap between research and practice to significantly
improve diabetes care."
The five other institutions involved in the TRIAD study are
the University of Michigan in Ann Arbor; the University of California
in Los Angeles (UCLA); Pacific Health Research Institute in Honolulu,
Hawaii; Kaiser Research Foundation Institute in Oakland, Calif.;
and the Indiana University School of Medicine in Indianapolis.
Approximately 18.2 million people in the U.S. currently have diabetes,
according to statistics provided by the CDC. Nearly 95 percent have
type 2 diabetes, which is associated with older age, obesity and
physical inactivity. It is projected that one in three Americans
will develop diabetes during their lifetime. For more information
on diabetes and projects such as TRIAD, visit the CDC Web site:
or call toll-free: 1-877-CDC-DIAB (232-3422).